Dementia is an umbrella term that describes impaired memory loss and changes to cognition in various medical conditions. While it’s commonly associated with older people, dementia isn’t a part Conclusion: Patients treated with gabapentin or pregabalin had an increased risk of dementia. Therefore, these drugs should be used with caution, particularly in susceptible individuals. Keywords: dementia, Alzheimer disease, cognitive impairment, gabapentin (GBP), pregabalin (PGB) And since treatment options for dementia are limited, prevention is key. Dementia risk is tied to common things like diabetes, high blood pressure, and physical inactivity. But some common medications are associated with dementia risk, too. Here are four common drug classes linked to dementia, and what the research says about your risk. 1. 153). Only in 2 out of 11 patients, the up-titration of GBP was limited by mild confusion (patient 1) and mild worsening of bal-ance (patient 7). Patient 1 did not tolerate any other agents, patient 7 did well with addition of a low dose of lorazepam, his nocturnal symptoms improved. Overall, GBP was well tolerated. These findings suggest a possible role for gabapentin in the behavioral management of patients with dementia. Patients with dementia experience progressive cognitive decline and may manifest a variety of behavioral symptoms. We describe a case where gabapentin was used to treat a patient with mixed Alzheimer's/vascular dementia presenting with severe aggression requiring hospitalization. The case is followed by a systematic review of current literature of the use of these drugs in aggression in patients with dementia. Pharmacodynamics of pregabalin and gabapentin Next, it is unclear whether gabapentin is equally efficacious in Alzheimer’s dementia versus concomitant Alzheimer’s and vascular dementia. Additionally, the age difference of 17?years may have also contributed to the 97-year old’s limited response to gabapentin. Also, the first patient received a total gabapentin dose of 300mg Moreover, dementia risk increased along with the cumulative dose. Taking an anticholinergic for the equivalent of three years or more was associated with a 54% higher dementia risk than taking the same dose for three months or less. The University of Washington study is the first to include nonprescription drugs. The evidence of gabapentin and dementia is mixed, with two studies looking at hundreds of thousands of people and coming to completely different conclusions. Optimizing Gabapentin Use In Elderly Patients. As we age, our bodies process medications differently, making it crucial to tailor treatment approaches for older adults. Optimizing gabapentin use in elderly patients involves careful consideration of dosing strategies, monitoring of kidney function, and exploring alternative or complementary Preliminary low-grade evidence based on case series and case reviews suggests possible benefit of gabapentin and pregabalin in patients with BPSD in Alzheimer's disease. These benefits cannot be confirmed until well-powered randomized controlled trials are undertaken. When medications are prescribed, preference should be given to medications with good evidence of efficacy in managing the underlying condition. That evidence would ideally come from studies in patient populations similar to those being treated, as studies of younger patients may not generalize to older adults, particularly those with ADRD. “Dementia comes with lots of behavioral issues, from changes in sleep and depression to apathy and withdrawal, and providers, patients and caregivers may naturally seek to address these through medications,” says Donovan Maust, M.D., M.S., the lead author of the study and an associate professor of psychiatry at Michigan Medicine, U-M’s More importantly, tests of cognitive decline administered during the study showed patients on commonly used antidepressants actually declined more slowly than what is typical for dementia patients This is unexpectedly good news, as it suggests we are making substantial progress in the fight against dementia. Experts have projected a marked rise in dementia cases driven by an aging New research found that taking medications such as aspirin or ibuprofen long-term is linked to a lower risk of dementia. But experts warn that this finding doesn’t apply to everyone. Management of the patient with dementia; Patient education: Caring for someone with Alzheimer disease or dementia (The Basics) Patient education: Dementia (including Alzheimer disease) (The Basics) Prognosis and treatment of dementia with Lewy bodies; Schizophrenia in adults: Guidelines for prescribing clozapine Dementia is a loss of brain function that affects memory, thinking, judgment, behavior, and language. Alzheimer's disease is the most common type of dementia. While there's no cure for dementia, medications can help manage or slow down symptoms, including memory loss. Medications may also help Our findings suggest that gabapentin should be considered for treating aggressive behavior in patients with vascular or mixed dementia and that it is well tolerated in this context. B ehavioral and psychological symptoms of dementia (BPSD) are common symptom manifestations in dementia. We present the case of a patient with incipient vascular dementia accompanied by nocturnal agitation, which was successfully treated with gabapentin. Gabapentin appears to be useful and well-tolerated in this indication.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | |
![]() | ![]() |